Ozempic and Wegovy contain semaglutide, which primarily targets the GLP-1 receptor
Because these medications directly affect appetite, weight, and food-related cues, they may interact in unintended ways with eating disorder symptoms and recovery processes
The Subscription Trend: Telehealth GLP-1, Lemme GLP-1 and Other Services Some companies now market subscription-based GLP-1 programs directly to consumers
For one, it allows for the creation of generic semaglutide compounding pharmacy versions, making the medication more accessible to a broader range of patients
Science: STEP-1 participants reached only 4 % by week 12
While evidence clearly supports bariatric surgery as a safe and effective treatment for obesity, emotional hesitation often overshadows medical facts